Competitor News, Oncology, RWE Study

Guardant Health Announces New Data from its Portfolio of Blood Tests and GuardantINFORM™ Real-World Clinical-Genomic Platform at IASLC 2022 World Conference on Lung Cancer

Posted on

Presentations to highlight role of liquid biopsy tests and real-world data in identifying resistance mechanisms to therapy, demonstrating impact of specific mutations on treatment efficacy, and informing therapeutic strategies in lung cancer August 05, 2022 08:05 AM Eastern Daylight Time PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading…

Competitor News, Fundraising/IPO

Atropos Health Announces $14M Series A, Taps Co-founder as CEO

Posted on

Atropos expands its board and names co-founder Brigham Hyde as chief executive. PALO ALTO, Calif., Aug. 4, 2022 /PRNewswire/ — Atropos Health, the leader in providing physicians with research-grade real-world evidence at the point of care, has announced the completion of a $14M Series A funding round. The company will use the funds to expand its commercial…

Competitor News, Europe, International

DARWIN EU: A transformation in the use of real-world health data for regulatory purposes in the EU

Posted on

New sources of evidence, such as big data in healthcare, offer opportunities to improve decision-making for better outcomes. However, uncertainties may exist around the quality of the data and the evidence being generated. In the EU, medicine regulators find that access to health care data is limited by different conditions…

Collaborations, Competitor News

Evio & Aetion Partner to Deliver Real-World Evidence (RWE) Across the Pharmacy Value Chain

Posted on

The Aetion Evidence Platform® will support Evio’s data-driven efforts to ensure every patient receives the right medication for their unique situation, from the beginning DENVER and NEW YORK, Aug. 4, 2022 /PRNewswire/ — Evio, an independent pharmacy solutions company dedicated to ensuring every patient receives the right medications in a simple and affordable way, today announced…

Collaborations, Competitor News, COVID-19, Data Partnership

Komodo Health Platform Selected by Stanford Medicine for Health Outcomes Research During the COVID-19 Pandemic

Posted on

August 04, 2022 08:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Today, Komodo Health announced that its platform will be used in studies led by Stanford Medicine focused on the short- and long-term health impacts of COVID-19. Researchers from Stanford’s Center for Population Health Sciences will utilize the Komodo Sentinel application,…

Collaborations, Competitor News

Havas Health & You Partners with Datavant to Power Personalized Patient-Provider Advanced Intelligence Engine

Posted on

VersaiSM , a Havas Health & You solution, Creates privacy protected 360-degree View of Patient and Provider Journeys Powered by Connected Medical and Consumer Data Sets NEW YORK and SAN FRANCISCO, Aug. 04, 2022 (GLOBE NEWSWIRE) — Datavant, the leader in helping organizations securely connect health data, has partnered with Havas…